EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of COVID - 19 Pandemic on The Clinical Course of Inflammatory Bowel Disease in Egyptian Tertiary Centers

Alaa Alsawak, Omar AbdAllah, Ali Madian, Hassan Atalla, Ramadan Eldamarawy, Ahmed Eliwa, Ahmed Khamiss, Ashraf El Sharkawy, Sadek Mostafa, Alshimaa Alaboudy, Maha M. Maher, Ashraf Elbahrawy

Mansoura Medical Journal · 01.01.2023 · 52 (1)

DOI: 10.58775/2735-3990.1371 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Mansoura Medical Journal, online erschienen am 01.01.2023. Verfasst von Alaa Alsawak und 11 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Aim: The coronavirus disease 2019 (Covid-19) pandemic have a major impact on the clinical course of chronic diseases including inflammatory bowel disease (IBD). In the current study we aimed to evaluate the clinical relapse and worsening of IBD activity during Covid-19 pandemic.

Methods

125 patients included and followed for one year. Of them, 98 and 27 patients had inactive and active IBD before the study, respectively. The clinical activity of IBD assessed by Crohn’s disease activity index (CDAI) and simplified colitis clinical activity index (SCCAI). Severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV-2) infection detected by real-time polymerase chain reaction.

Results

The mean age of included patients was 34.3 ±11.2 years, of them 54(43.2%) were males. 43(34.4%) and 82(65.6%) patients had Crohn’s disease (CD) and ulcerative colitis (UC), respectively. 46 (47%) patients developed clinical relapse within one year. Of them 22 (48%) patients were not adherent to treatment during the pandemic (P ≤ 0.05). 33.3% of patients with active IBD before the study, had worsened activity during the pandemic. The incidence of SARS-CoV-2 infection among included patients was 8 % (n=10).

Conclusion

The majority of relapsed IBD patients were not adherent to treatment due to the fear of Covid-19 infection.

Zitieren

APA

Alsawak, A., AbdAllah, O., Madian, A., Atalla, H., Eldamarawy, R., Eliwa, A., Khamiss, A., Sharkawy, A. E., Mostafa, S., Alaboudy, A., Maher, M. M., & Elbahrawy, A. (2023). Impact of COVID - 19 Pandemic on The Clinical Course of Inflammatory Bowel Disease in Egyptian Tertiary Centers. Mansoura Medical Journal, 52(1). https://doi.org/10.58775/2735-3990.1371

Vancouver

Alsawak A, AbdAllah O, Madian A, Atalla H, Eldamarawy R, Eliwa A, et al. Impact of COVID - 19 Pandemic on The Clinical Course of Inflammatory Bowel Disease in Egyptian Tertiary Centers. Mansoura Medical Journal. 2023;52(1). doi:10.58775/2735-3990.1371

BibTeX
@article{Alsawak2023,
  author = {Alsawak, Alaa and AbdAllah, Omar and Madian, Ali and Atalla, Hassan and Eldamarawy, Ramadan and Eliwa, Ahmed and Khamiss, Ahmed and Sharkawy, Ashraf El and Mostafa, Sadek and Alaboudy, Alshimaa and Maher, Maha M. and Elbahrawy, Ashraf},
  title = {Impact of COVID - 19 Pandemic on The Clinical Course of Inflammatory Bowel Disease in Egyptian Tertiary Centers},
  journal = {Mansoura Medical Journal},
  year = {2023},
  volume = {52},
  number = {1},
  doi = {10.58775/2735-3990.1371}
}
Kostenlos starten →